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Abstract
Background: To address shortages of mental health specialists in low‐ and middle‐
income countries, task‐shifting approaches have been employed to train non-
specialists to deliver evidence‐based scalable psychosocial interventions. Problem
Management Plus (PM+) is a brief transdiagnostic nontrauma focused intervention
for people affected by adversity. This study reports on the capacity of PM+ to
address specific symptoms of posttraumatic stress disorder (PTSD).
Methods: Individual patient data from three randomised controlled trials were
combined and analysed to observe the impacts of PM+ (n = 738) or enhanced
treatment as usual (ETAU) (n = 742) interventions on specific PTSD symptoms at
posttreatment and 3‐month follow‐up. The PTSD‐Checklist for DSM‐5 (PCL‐5) was
used to index PTSD symptoms, and presence of each symptom was defined as
moderate severity (score ≥ 2 on individual items).
Results: The average PCL‐5 score at baseline was 26.1 (SD: 16.8) with 463 (31.3%)
scoring above 33, indicative of a diagnosis of PTSD. Following intervention, 12.5%
and 5.8% of participants retained a score greater than 33 at postassessment and
follow‐up, respectively. There was greater symptom reduction for PM+ than for
ETAU for most symptoms. Hyperarousal symptoms were the most common residual
symptoms after PM+, with more than 30% of participants reporting persistent sleep
disturbance, concentration difficulties, and anger.
Conclusion: PM+ led to greater reduction in symptoms relating to re‐experiencing
and avoidance. The evidence indicates that strategies focusing on hyperarousal
symptoms including sleep, concentration, and anger difficulties, could be strength-
ened in this brief intervention.
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1 | INTRODUCTION
People affected by war, conflict, and humanitarian crises dis-
proportionately live in low‐ and middle‐income countries (LMICs),
and they are at increased risk for psychological problems (Barbui &
Tansella, 2013; Charlson et al., 2019). This is not surprising because
these vulnerable populations can be exposed to significant adversity,
including poverty, sexual violence, torture, war, and displacement.
Despite the prevalence of mental health problems in LMICs, including
people living in humanitarian contexts, it is estimated that at least
90% of adults with mental health needs do not receive minimum
adequate care (Chisholm et al., 2016). Programs exist that can
address mental health conditions in these typically poor resource
settings (Morina et al., 2017a, 2017b), but they are often not
implemented because (a) these interventions tend to only target a
single diagnostic outcome (e.g., posttraumatic stress disorder (PTSD;
(Neuner et al., 2008)), (b) are generally resource and time intensive
(Bolton et al., 2007), and (c) often require mental health specialists
who are lacking in LMICs (Bass et al., 2013). These factors preclude
many LMICs and humanitarian responses from implementing much‐
needed mental health services that their populations require (Patel
et al., 2018; Tol et al., 2012).
This situation has led to increased recognition that addressing
the mental health and psychosocial needs of people in humanitarian
crisis settings requires transferring a portion of mental health delivery
to trained and supervised nonspecialist workers. This shift is ap-
pealing in low resource settings because it overcomes the limitation
of the scarcity of mental health specialists, reduces costs, and can
minimize stigma associated with specialist mental health care
(Patel et al., 2018). Increasingly, programs have utilized these “task‐
shifting” approaches in which local providers who lack formal
mental health qualifications are trained to deliver structured
manualized interventions for common mental disorders. One
meta‐analysis found these interventions are moderately effective in
LMICs (Singla et al., 2017).
TheWorld Health Organization (WHO) has recently adopted this
approach by developing a range of mental health interventions that
are intended to address common mental disorders (i.e., anxiety and
depression) in populations affected by adversity. Inherent in this
approach is that these interventions are brief, affordable, can be
easily trained to nonspecialists, and in this manner can be scaled up
to achieve maximum reach in an LMIC and with limited resources.
The first program of this type developed by the WHO was titled
Problem Management Plus (PM+), a transdiagnostic intervention that
involves five sessions that teach people skills that have been shown
to be the most effective in reducing common mental disorders in
controlled trials (Dawson et al., 2015). Specifically, PM+ teaches
nonspecialist providers to train people with common mental
disorders skills in arousal reduction, problem‐solving, behavioral
activation, and strengthening social supports. PM+ delivered to in-
dividuals has been shown to be effective in reducing psychological
distress in adverse settings. The two large trials comprised women
affected by gender‐based violence in Kenya (Bryant et al., 2017) and
men and women in in a conflict‐affected region in Pakistan (Rahman
et al., 2016). Additionally, PM+ has been delivered in a group format
in Pakistan, which has also been shown to be effective relative to
treatment as usual (Rahman et al., 2019).
Despite the overall efficacy of PM+ in reducing psychological
distress and symptoms of common mental disorders, there is a need
to better understand how it impacts specific psychological symptoms
following adversity, such as the experiences of people who have lived
through interpersonal trauma or humanitarian crises. One treatment
study of female veterans with PTSD that employed trauma‐focused
cognitive behaviour therapy (TF‐CBT) found that hyperarousal
symptoms, and especially sleep problems and irritability, were most
resistant to change with treatment (Schnurr & Lunney, 2019). This
finding accords with a trial of female rape survivors with PTSD, and
found that sleep problems were most resistant to TF‐CBT (Larsen
et al., 2019). The finding that many people continue to experience
functional difficulties following remission of PTSD diagnosis (Bryant
et al., 2016) points to the need to better understand psychological
difficulties that persist after treatment. Although some inroads have
been made in relation to trauma‐focused psychotherapies, there is a
need to understand how scalable interventions, such as PM+, address
specific PTSD symptoms in humanitarian and development contexts
where the prevalence of PTSD is elevated (Charlson et al., 2019). This
is relevant for PM+ because although it is not a trauma‐focused in-
tervention, previous trials have shown that PM+ leads to significant
reductions in PTSD severity, in adversity‐affected LMICs and conflict
settings (Rahman et al., 2016, 2019). In both situations, many people
in these category do suffer from PTSD, or experience events that
could lead to PTSD. In turn, understanding the residual symptoms of
PTSD following PM+ would provide information on how the inter-
vention reduces PTSD symptoms as well as inform the development
of future scalable interventions.
To this end, this study conducts an individual‐patient data
meta‐analysis (IPD‐MA) of the three large controlled trials that have
been published to determine which symptoms of PTSD are most
persistent after provision of PM+ (Bryant et al., 2017; Rahman
et al., 2016, 2019). It further aims to inform the potential of PM+ to
be a useful brief intervention across humanitarian and adversity
settings where PTSD is considered one of the common mental
disorders experienced.
2 | METHODS
2.1 | Materials and methods
This IPD analysis focused on prospectively registered randomized
clinical trials (RCT) of individual PM+ in Pakistan ((Rahman
et al., 2016), ACTRN12614001235695) and Kenya ((Bryant
et al., 2017), ACTRN12616000032459), and group PM+ in Pakistan
((Rahman et al., 2019), ACTRN12616000037404). Details about the
original studies have been published elsewhere (Chiumento
et al., 2017; Sijbrandij et al., 2015, 2016). Initial studies of the
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PM+ manual required approval of their research protocols through
the WHO Ethical Review Committee in addition to the relevant
governing bodies in countries that the trials were conducted.
All participants provided written informed consent before taking part
in the trials.
2.2 | Context and participants
Between November 2014 and August 2016 three RCTs were con-
ducted to evaluate the effectiveness of PM+ in reducing the levels of
psychological distress experienced by participants. A secondary
outcome of each trial included PTSD symptoms. Data from these
studies were combined into a single data set.
The study characteristics are presented inTable 1. In the Pakistan
individual PM+ study, participants (N = 346) were recruited from
three primary health care centres in the conflict‐affected urban city
of Peshawar (Rahman et al., 2016). Participants received clinical as-
sessments from their physicians; participants who were deemed to
be suffering from psychological distress were referred to the study.
The Pakistan group‐based PM+ study was conducted in two rural
council districts of Swat (Rahman et al., 2019), and adult women
(N = 612) were randomly screened in the community and invited into
the study if they screened positively for psychological distress. The
Kenya study recruited female participants (N = 522) through random
sampling in peri‐urban neighbourhoods of Nairobi, of whom 81% had
experienced gender‐based violence (Sijbrandij et al., 2016). In all
three studies the initial screening procedure used the General Health
Questionnaire‐12 (GHQ‐12; (Goldberg & Williams, 1988; Minhas &
Mubbashar, 1996)) to identify psychological distress and the
WHO‐Disability Assessment Schedule 2.0 (WHODAS 2.0), which is a
12‐item measure of general functioning (WHO, 2010). The common
inclusion criteria across all three studies were (i) adults aged 18–60
years, (ii) score of ≥3 on the GHQ‐12, and (iii) score of ≥17 on the
WHODAS 2.0. The exclusion criteria were identical across all three
studies: (i) imminent risk for suicide, (ii) severe mental illness
(e.g., psychotic disorders, substance use disorders), and (iii) significant
cognitive and neurological impairment (e.g., severe intellectual
disability).
2.3 | Interventions
2.3.1 | Problem Management Plus
PM+ integrates problem‐solving and behavioural activation
techniques that are amenable to low‐intensity delivery and are
evidence‐based (Bennett‐Levy & Farrand, 2010; Cuijpers et al., 2007;
Farchione et al., 2012; van't Hof et al., 2011). The individual format is
delivered over five weekly sessions of 90min duration; the group
format is delivered over five weekly sessions of 120min duration.
Clients are taught: (i) arousal reduction; (ii) problem management;
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The PM+ programme has been made available publicly by the WHO
(WHO, 2016). Facilitators received 8 days of training in basic coun-
selling skills and the delivery of the PM+ intervention. For the group
modality, facilitators are additionally taught group facilitation skills.
Following training, the PM+ providers are required to complete two
practice cases whilst attending weekly group supervision sessions
focused on fidelity to the intervention, challenges faced, and helpers
self‐care.
2.3.2 | Enhanced treatment as usual (ETAU)
The ETAU arms of all three studies included psychoeducation and
referral information for locally available resources for health, voca-
tional training, and other relevant services. Participants were pro-
vided with individual, verbal feedback regarding the results of the
assessments, brief psychoeducation and referral services to primary
health care centres in both Kenya and the Swat trial, and participants
met with a primary healthcare physician at least once where they
received assessment feedback and a psychoeducation session in the
Peshawar study.
2.4 | Measure
PTSD symptoms were measured using the PTSD Checklist for DSM‐5
(PCL‐5) (Weathers et al., 2013). The PCL‐5 is a 20‐item checklist
corresponding to the 20 symptoms for PTSD as defined in DSM‐5.
There are five items corresponding to intrusion symptoms, two to
avoidance symptoms, seven to negative alterations in cognitions and
moods, and six to alterations in arousal and reactivity. Items are rated
on a 5‐point Likert scale (0 = not at all, 4 = extremely) and total scores
are obtained by summing the responses for individual items (range:
0–80). Across all three studies, the PCL‐5 was adapted to ask for
symptoms in the past week (instead of month) to enhance sensitivity
to change. The PCL‐5 measure was adapted in all three studies in
accordance with gold‐standard translation practices, with each item
being translated and back‐translated by accredited translators
(Bontempo, 1993). In Kenya, items were translated into Kiswahili and
in Pakistan, items were translated into Urdu. The comprehensibility
of the adapted versions were piloted in feasibility trials which took
place before the RCTs (Dawson et al., 2016; Rahman et al., 2016).
The psychometric properties of the PCL‐5 have been widely studied
and has been shown to have high levels of diagnostic accuracy and
internal consistency (Blevins et al., 2015; Bovin et al., 2016), including
in LMIC (Mughal et al., 2020). Symptoms were rated as present if the
respondent indicated that they were at least moderately bothered by
them, as indicated by a score ≥2 on individual items (Weathers
et al., 2013). Symptom retention was defined as the conditional
probability of retaining a symptom at posttreatment and 3‐month
follow‐up compared to before receiving treatment. A probable
diagnosis of PTSD is made if the total score on the PCL‐5 was ≥33
(Weathers et al., 2013).
2.5 | Statistical analysis
Means and SD are reported for continuous variables while fre-
quencies and percentages are reported for categorical variables.
Missing outcome data at postintervention and follow‐up assessments
were estimated using multiple imputation (MI); data were assumed to
be missing‐at‐random. As the PCL‐5 results are scored on a Likert
scale, MI was conducted by chained equations using ordered logistic
regression (mi impute chained ologit in Stata). We analysed the ef-
fects of PM+ versus ETAU on the conditional probability that parti-
cipants retained symptoms following intervention using a multilevel
logistic regression, with random effects for each trial; separate
models were run for each of the 20 PTSD symptoms. A complete‐
case sensitivity analysis was conducted to explore robustness of re-
sults from the MI using only participants who completed the post and
follow‐up assessments. Results are reported as the estimated odds
ratio (OR) and the 95% confidence intervals (CI) for each symptom
are presented. All analyses were conducted using Stata 13
(StataCorp., 2013).
3 | RESULTS
Descriptive information about study participants is presented in
Table 2. In total, 1480 participants were randomised across the three
trials, with 738 receiving the PM+ intervention and 742 receiving
ETAU. There were 1154 (78.0%) participants who completed the
postintervention assessment and 1,273 (86.0%) who completed
the 3‐month follow‐up assessments. The average age of the study
participants was 35.31 years (SD = 11.84). The studies comprised
1407 women (95%).
The average PCL‐5 score at baseline was 26.1 (SD = 16.76) while
463 (31.3%) participants scored ≥33, indicating that it was probable
they meet diagnostic criteria for PTSD. There were 230 (31.21%) and
233 (31.53%) persons who scored ≥33 on the PCL‐5 at baseline
randomized in the PM+ and ETAU arms, respectively. The Kenya and
individual PM+ Pakistan trials had higher baseline PCL‐5 scores
(31.76 and 31.05, respectively) and numbers of people with probable
PTSD (46% and 45%, respectively) compared to the baseline PTSD
levels in the Swat study (M = 18.51, 11% > 33). At postintervention
assessment, 5.19% of people who received PM+ and 8.39% of people
who received ETAU reported a score ≥33 and at 3‐month follow‐up,
2.72% (PM+) and 3.85% (ETAU) had a score ≥33. For those who
scored ≥33 at baseline, 11.93% and 20% (postintervention), and
5.95% and 8.60% (3‐month follow‐up) maintained a score of ≥33 in
the PM+ and ETAU arms, respectively.
Figure 1 illustrates the proportions of participants that were
randomised to receive PM+ and who scored positive for symptom
presence at baseline, postintervention, and 3‐month follow‐up. The
most prevalent symptoms at baseline were irritability/aggression,
difficulty concentrating, and sleeping (i.e., arousal symptoms). The
least prevalent symptoms were inability to recall the trauma, ex-
aggerated blame, and risky/destructive behavior. Following
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treatment, at both postintervention and 3‐month assessment, arousal
symptoms remained the most prevalent, although the proportions of
individuals who were positive for these arousal symptoms decreased
markedly. Mood symptoms were among the lowest reported fol-
lowing PM+ at both postintervention time points, although risky
behavior (an arousal symptom) was the least prevalent at all three
time points.
Figure 2 illustrates the prevalence of PTSD symptoms for those
who received ETAU. The baseline rates were similar to participants
who received PM+. Even though this group showed marked reduc-
tions of symptoms of PTSD, the prevalence of all symptoms were
higher than the PM+ participants; particularly mood and arousal
symptoms. This was also true at 3‐month follow‐up.
Tables 3 and 4 present the proportions of individuals who re-
tained symptoms following intervention (Table 3) and at 3 months
(Table 4); they also present the ORs and corresponding 95% CI.
Across all 20 symptoms, there were higher rates of amelioration of
symptoms for those who received PM+ compared to those who re-
ceived ETAU, with the largest effects seen in mood and arousal
symptoms. The symptoms with the greatest absolute remission fol-
lowing the PM+ intervention were avoidance of thoughts and be-
haviours. When comparing the conditional probabilities of symptom
retention immediately following interventions and at 3‐month follow‐
up, the ORs point estimates indicate that participants receiving the
ETAU intervention had higher odds of symptom retention that those
who received PM+, when compared to baseline. Specifically, the odds
of symptoms amelioration were significantly higher for those who
received PM+ compared to ETAU in: physical reactivity, avoidance of
thoughts, avoidance of people/places, negative affect, decreased
interest, difficulty with positive affect, irritability/aggression,
TABLE 2 Demographic and clinical characteristics of the study population (n = 1480)
Kenya (N = 522) Pakistan (N = 346) SWAT (N = 612) Combined (N = 1480)
Randomization
PM+, N 260 172 306 738
ETAU, N 262 174 306 742
Age, mean (SD) 35.95 (13.66) 33.08 (11.80) 36.26 (9.88) 35.41 (11.84)
Education (years), mean (SD) 8.50 (3.98) ‐ ‐ ‐
Education ‐
No schooling, N (%) ‐ 203 (58.7%) 503 (82.2%) ‐
Primary (6 years), N (%) ‐ 42 (12.1%) 51 (8.3%) ‐
Middle (8 years), N (%) ‐ 26 (7.5%) 22 (3.6%) ‐
Matriculate (10 years), N (%) ‐ 29 (8.4%) 18 (2.9%) ‐
Intermediate, college and university
(11–16 years), N (%)
‐ 46 (13.3%) 15 (2.5%) ‐
Gender, N (%)
Female 522 (100) 273 (78.90) 612 (100) 1407 (95.07)
Male 0 (0) 73 (21.10) 0 (0) 73 (4.93)
PCL‐5, mean (SD) PM+ ETAU PM+ ETAU PM+ ETAU PM+ ETAU
Baseline 32.86 (20.10) 30.67 (19.17) 31.81 (14.34) 30.30 (14.22) 17.26 (11.04) 19.75 (11.70) 26.14 (17.21) 26.06 (16.14)
Postintervention 9.62 (12.54) 13.36 (15.74) 12.86 (10.69) 18.73 (11.11) 8.66 (9.17) 12.41 (8.29) 9.75 (10.76) 13.73 (12.03)
3‐month 7.56 (11.42) 7.41 (10.40) 11.90 (9.18) 17.72 (9.35) 8.48 (6.47) 10.92 (7.96) 9.00 (9.01) 11.52 (9.88)
PTSD diagnosis
Baseline 126 (48.65) 115 (44.40) 77 (44.77) 77 (44.25) 27 (8.82) 41 (17.60) 230 (31.21) 233 (31.53)
Postintervention 13 (6.40) 31 (14.49) 9 (7.89) 12 (12.63) 10 (3.33) 8 (2.68) 32 (5.19) 51 (8.39)
3‐month 9 (4.71) 6 (3.02) 6 (4.11) 12 (7.50) 2 (0.69) 7 (2.41) 17 (2.72) 25 (3.85)
PTSD diagnosis retention
Postintervention, N (%) 12 (12.24) 28 (28.00) 5 (9.80) 7 (15.56) 4 (14.81) 2 (5.00) 21 (11.93) 37 (20.00)
3‐month, N (%) 7 (7.14) 5 (5.95) 4 (6.35) 7 (10.61) 0 (0.00) 4 (11.11) 11 (5.95) 16 (8.60)
Abbreviations: ETAU, enhanced treatment as usual; PM+, problem management plus.
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heightened startle reaction, difficulty concentrating, and difficulty
sleeping. At 3‐month follow‐up, significant reductions in symptom
rates were maintained for: physical reactivity, avoidance of people/
places, decreased interest, irritability/aggression, heightened startle
reactions, difficulty concentrating, and difficulty sleeping. In addition,
at 3‐month follow‐up, the following symptoms had significantly
higher odds of being reduced in those who received PM+ compared
to ETAU: negative thoughts/assumptions and hypervigilance. There
were no changes in the results of the sensitivity analysis; this in-
dicates robustness of the primary analysis strategy.
F IGURE 1 Problem management plus—symptom presence for each posttraumatic stress disorder symptom at baseline, postintervention
assessment, and 3‐month follow up
F IGURE 2 Enhanced treatment as usual—symptom presence for each posttraumatic stress disorder symptom at baseline, postintervention
assessment, and 3‐month follow up
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4 | DISCUSSION
We examined the residual symptoms of PTSD following a low‐
intensity intervention across urban, peri‐urban, and rural samples in
three major trials in two LMICs, Kenya and Pakistan. We found that
PM+ resulted in higher alleviation of symptoms when compared to
ETAU. This was most notable across avoidance, cognition/mood, and
arousal symptoms. These trends were similar at both postinterven-
tion assessments and 3‐month assessments.
PM+ had a significant impact on the alleviation of avoidance
symptoms when compared to ETAU immediately following the
program. Moreover, there was approximately a 75% reduction of
re‐experiencing symptoms (e.g., intrusive memories, nightmares,
flashbacks). These are interesting findings insofar as PM+ is not a
trauma‐focused intervention, and does not directly target emotional
processing of trauma memories or avoidance of trauma reminders.
Trauma‐focused therapies purportedly lead to reduction of PTSD
symptoms because they promote emotional processing of trauma
memories and associated emotions through explicit exposure to
trauma memories, which can facilitate extinction learning of pre-
viously learnt association of fear (Foa, 2006). It is possible that the
use of problem‐solving, behavioural activation, and social support in
PM+ prompts participants to engage in activities that facilitate
emotional processing because of discussion about core problems or
TABLE 3 Percentage of participants
retaining each posttraumatic stress
disorder symptom after treatment by
treatment type—postassessment
PM+ ETAU Multiple imputation Complete case
Item % N % N OR 95% CI OR 95% CI
B–1 Intrusive memories 15.25 34 21.61 51 1.44 0.92–2.26 1.53 0.95–2.49
B–2 Nightmares 15.03 26 22.83 42 1.53 0.90–2.62 1.66 0.96–2.87
B–3 Flashbacks 14.37 37 20.56 37 1.42 0.82–2.45 1.54 0.88–2.69
B–4 Emotional distress 23.50 51 27.87 68 1.27 0.85–1.90 1.28 0.83–1.96
B–5** Physical reactivity 21.78 49 29.66 70 1.57 1.05–2.35 1.68 1.09–2.60
C–1** Avoidance of
thoughts
12.89 25 22.39 45 1.89 1.13–3.17 2.04 1.18–3.52
C–2** Avoidance of
people/places
11.48 21 20.99 38 2.01 1.10–3.66 2.13 1.17–3.88
D–1 Dissociative
amnesia
8.39 13 15.15 25 1.75 0.93–3.31 1.96 0.96–3.99
D–2 Negative thoughts/
assumptions
18.58 34 21.80 46 1.23 0.76–1.97 1.26 0.76–2.08
D–3 Exaggerated blame 17.76 27 23.35 39 1.22 0.72–2.09 1.41 0.81–2.44
D–4** Negative affect 18.58 32 33.45 92 2.07 1.38–3.10 2.33 1.51–3.57
D–5** Decreased
interest
19.41 66 42.36 158 2.88 2.05–4.05 3.09 2.20–4.35
D–6 Feeling isolated 15.47 28 22.53 41 1.59 0.95–2.67 1.60 0.93–2.74
D–7** Difficulty with
positive affect
9.66 17 22.35 38 2.40 1.32–4.34 2.69 1.45–4.99
E–1** Irritability/
aggression
31.33 125 57.01 240 2.73 2.05–3.63 3.02 2.24–4.07
E–2 Risky/destructive
behaviour
10.34 9 16.67 15 1.56 0.70–3.50 1.79 0.73–4.39
E–3 Hypervigilance 32.45 86 40.14 112 1.28 0.87–1.89 1.34 0.91–1.96
E–4** Heightened startle
reaction
23.65 79 46.23 147 2.72 1.93–3.84 2.88 2.04–4.07
E–5** Difficulty
concentrating
21.43 75 44.88 149 2.78 1.98–3.91 3.09 2.18–4.37
E–6** Difficulty sleeping 30.10 115 48.97 190 2.16 1.60–2.91 2.23 1.66–3.00
Note: Significant values are underlined.
Abbreviations: CI, confidence interval; ETAU, enhanced treatment as usual; OR, odds ratio;
PM+, problem management plus.
**p < .05.
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approaching previously avoided situations that are reminiscent of the
traumatic experience. It is also possible that the focus on problem‐
solving skills in PM+ may address aspects of avoidant behaviors; for
example, problem‐solving approaches to being reluctant to shop at a
local market because it reminds a person of being at a market when it
was bombed may lead to proactive strategies to return to markets,
thereby implicitly engaging in in vivo exposure activities. Further,
TF‐CBT is intended to involve integration of new information that
corrects excessively negative appraisals about the person and their
world (Ehlers & Clark, 2000). Problem‐solving and behavioural
activation strategies may result in beliefs about danger of one's en-
vironment or one's inadequacy may be alleviated by these strategies,
which could also reduce avoidance behaviors. The finding that the
superior effect regarding avoidance thoughts was not observed at 3
months may point to the potential benefit of providing booster
sessions to maintain the relative benefits of PM+.
The finding that negative cognitive and mood symptoms were
better addressed by PM+ than ETAU may also be attributed to the
behavioral activation components of PM+ intervention. There is
considerable evidence that behavioral activation reduces low mood
(Ekers et al., 2014), arguably because it prompts individuals to engage
in potentially pleasurable activities that can increase their sense of
reward. Behavioral activation may additionally promote self‐efficacy
through successful completion of tasks, which in turn can improve
self‐esteem and self‐related appraisals (Benight & Bandura, 2004).
Further, the act of problem‐solving itself can promote self‐mastery
because it facilitates the perception that one can influence outcomes,
thereby potentially reducing learned helplessness and enhancing
mood (Cassidy & Long, 1996).
At follow‐up there were fewer PM+ participants with arousal
symptoms, relative to those who received ETAU, including hypervi-
gilance, startle response, concentration difficulties, anger, and sleep
disturbance. One of the core strategies of PM+ aims to reduce
arousal via simple techniques, primarily deep breathing strategies.
Previous research has found a number of breathing‐based techniques
helpful for persons with PTSD, specifically in reducing hyperarousal
symptoms (Seppälä et al., 2014). Moreover, meta‐analyses indicate
that slow breathing is efficacious in reducing a range of arousal
TABLE 4 Percentage of participants retaining each posttraumatic stress disorder symptom after treatment by treatment type—3‐month
follow‐up
PM+ ETAU Multiple imputation Complete case
Item % N % N OR 95% CI OR 95% CI
B–1 Intrusive memories 12.72 29 13.01 32 1.03 0.61–1.74 1.02 0.59–1.75
B–2 Nightmares 9.50 17 15.08 30 1.58 0.88–2.85 1.69 0.90–3.19
B–3 Flashbacks 11.24 20 17.01 33 1.50 0.84–2.67 1.62 0.89–2.94
B–4 Emotional distress 16.29 36 18.88 47 1.22 0.77–1.93 1.21 0.75–1.96
B–5** Physical reactivity 15.42 37 24.81 66 1.73 1.12–2.68 1.85 1.18–2.91
C–1 Avoidance of thoughts 13.17 27 17.13 37 1.47 0.85–2.54 1.45 0.83–2.54
C–2** Avoidance of people/places 12.50 23 19.07 37 1.83 1.03–3.24 1.88 1.05–3.36
D–1 Dissociative amnesia 4.82 8 8.24 14 1.63 0.67–3.97 1.78 0.73–4.38
D–2** Negative thoughts/assumptions 10.05 20 20.17 47 2.29 1.31–4.00 2.38 1.34–4.23
D–3 Exaggerated blame 9.68 15 11.18 19 1.19 0.60–2.39 1.17 0.57–2.40
D–4 Negative affect 25.64 60 27.46 81 1.12 0.76–1.66 1.14 0.77–1.70
D–5** Decreased interest 20.87 72 29.63 112 1.58 1.12–2.23 1.59 1.12–2.24
D–6 Feeling isolated 9.84 18 13.44 25 1.43 0.76–2.67 1.41 0.73–2.70
D–7 Difficulty with positive affect 6.70 12 11.60 21 1.56 0.76–3.20 1.66 0.78–3.52
E–1** Irritability/aggression 36.63 152 50.23 221 1.68 1.26–2.24 1.74 1.30–2.33
E–2 Risky/destructive behaviour 3.16 3 8.49 9 1.67 0.53–5.26 2.84 0.75–10.84
E–3** Hypervigilance 26.92 70 37.41 107 1.59 1.04–2.42 1.73 1.12–2.67
E–4** Heightened startle reaction 18.42 63 34.95 115 2.33 1.61–3.37 2.53 1.73–3.68
E–5** Difficulty concentrating 23.10 82 38.19 131 2.02 1.45–2.83 2.13 1.50–3.01
E–6** Difficulty sleeping 28.32 111 41.27 175 1.74 1.29–2.34 1.81 1.34–2.45
Note: Significant values are underlined.
Abbreviations: CI, confidence interval; ETAU, enhanced treatment as usual; OR, odds ratio; PM+, problem management plus.
**p < .05.
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symptoms, including anger, sleep disturbance, and poor concentra-
tion (Zaccaro et al., 2018). Thus it is unsurprising that teaching par-
ticipants diaphragmatic breathing during the course of PM+ led to
reductions in arousal‐related problems of PTSD.
Although PM+ resulted in reductions of arousal‐related pro-
blems, hyperarousal symptoms tended to be the most resistant to
remission across both arms. Consistent with prior trials that have
employed trauma‐focused psychotherapy for PTSD (Larsen
et al., 2019; Schnurr & Lunney, 2019), this study found that sleep
problems was the most retained symptom, followed by hypervigi-
lance, startle response, anger, and concentration difficulties 3 months
after PM+. This finding across treatment trials underscores the re-
cognition that sleep disturbance is a common transdiagnostic pro-
blem for many people with psychological distress which might
assume independent status as distinct from other presenting diag-
noses (Spoormaker & Montgomery, 2008; Zayfert & DeViva, 2004).
Sleep impairment is a commonly persistent problem after treatment
for depression (Menza et al., 2003), suggesting that lingering sleep
difficulties in participants may be associated with ongoing depres-
sion. It is also worth noting that many participants in the current trials
lived in harsh conditions, largely characterized by poverty, potential
interpersonal threats, and other forms of adversity. Such conditions
can result in arousal symptoms reflecting reactions to imminent
threats rather than being symptomatic of a psychological condition.
This remains a major challenge for scalable, transdiagnostic inter-
ventions given the cyclic nature of sleep impairment contributing to
marked impairment in PTSD and various other mental health condi-
tions (Harvey & Tang, 2012; Werner et al., 2019).
The reduction of symptoms for participants who received ETAU
is additionally noteworthy. Several explanations may be considered
to account for this pattern. First, ETAU involved providing partici-
pants with psychoeducation following their baseline assessment. On
its own, this may have been beneficial, as supported by evidence that
psychoeducation can reduce some PTSD symptoms (Hadar Lubin
et al., 1998; Swan et al., 2017). Second, there is evidence that re-
peated assessments themselves may result in reduction of symptom
reporting, which formed part of the methologies in these trials
(Tarrier et al., 1999).
PM+ was intended to be a low‐intensity, scalable intervention
allowing for task‐sharing in low‐resourced, adverse and humanitarian
settings. The intervention aimed to address the mental health gap
while alleviating the burden on specialized services. Additionally, it
was developed with the intention of being transdiagnostic insofar as
it would address symptoms across multiple common mental dis-
orders. Having better insight into the specific symptoms impacted by
the intervention will allow for more effective and targeted inter-
ventions in the future. For example, knowledge that PM+ contributes
to reducing symptoms of PTSD may make this intervention more
viable in postconflict humanitarian contexts. Further, understanding
which symptom clusters are resistant to PM+ allows for the devel-
opment and inclusion of additional psychological strategies as active
components. These future developments are important as PM+ is
being successfully adapted to augment treatment in specialist mental
health care facilities (Hamdani et al., 2021) and also in high‐income
countries with advanced health resources (de Graaff et al., 2020).
5 | LIMITATIONS AND FUTURE
RESEARCH
We note several methodological limitations. First, two of the three
included studies only enrolled women, which may limit the general-
izability of these findings beyond female populations. Recruitment of
males can be difficult in humanitarian crisis settings (Affleck
et al., 2018), however there are sex differences in both PTSD and in
treatment response (Olff, 2017). Therefore, continued understanding
about how gender impacts symptom remission remains important.
Second, the trial participants were selected due to heightened levels
of psychological distress and no formal diagnostic assessments via
structured clinical interviews were conducted. Third, there was a
large difference on average baseline scores as well as the number of
participants who scored ≥33 on the PCL‐5 in Kenya/Peshawar and
Swat. This may be attributed to the different contexts and partici-
pants selected; Kenya data was based only on women who had a
reported history of gender‐based violence, while the Peshawar study
recruited participants in a high‐stress environment where acute
conflict was commonplace. In contrast, the Swat trial participants
were recruited from rural districts affected by chronic conflict and
natural disaster. In the context, we also note that there is no con-
vergent evidence regarding the recommended cut‐off scores on the
PCL‐5 to identify probable PTSD in humanitarian settings. Fourth,
trials were not able to collect detailed information about usual care
treatments that participants received instead of PM+. Being able to
compare the ETAU interventions across studies to look at com-
monalities and differences would allow for a better understanding of
the patterns and results observed across the three trials. Lastly, we
recognize that meeting diagnostic criteria was not a prerequisite for
entry into the studies.
6 | CONCLUSION
As transdiagnostic programs are increasingly delivered by lay provi-
ders, it is important to understand how these programs impact on
specific symptoms across a range of disorders. This is the first study
to investigate the direct effects of PM+ on the residual symptoms on
PTSD. Although PM+ was designed as a transdiagnostic intervention
and is not specifically a trauma‐focused treatment, it is a valuable
finding that it was still effective to reduce many core PTSD symp-
toms, including re‐experiencing and avoidance symptoms. Im-
portantly, PM+ was less successful in reducing certain hyperarousal
symptoms, which may reflect ongoing problems associated with living
in contexts of adversity, poverty, and humanitarian crisis. Identifying
residual symptoms that persist after PM+ will assist future develop-
ment of programs that could address lingering problems that people
experience after receiving brief transdiagnostic programs.
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